Table 2.
Basic parameters of peripheral blood morphology in RVO patients and controls.
| Parameter | RVO (n = 35) | CRVO (n = 21) | BRVO (n = 13) | Controls (n = 35) |
|---|---|---|---|---|
| RBC (×06) [cells/µL] | 4.67 (4.39; 4.86) | 4.67 (4.39; 4.86) | 4.55 (4.39; 4.86) | 4.59 (4.33; 4.91) |
| WBC (×103) [cells/µL] | 6.75 (5.58; 7.69) # | 7.49 (6.54; 8.84) # | 6.67 (5.33; 6.98) | 5.77 (4.98; 6.68) |
| NEU (×103) [cells/µL] | 3.90 (3.10; 4.87) # | 4.35 (3.77; 5.22) # | 3.5 (2.78; 3.9) | 3.30 (2.63; 4.28) |
| EOS (×103) [cells/µL] | 0.18 (0.10; 0.32) # | 0.2 (0.12; 0.29) | 0.14 (0.10; 0.32) | 0.11 (0.08; 0.19) |
| BAS (×103) [cells/µL] | 0.05 (0.04; 0.07) # | 0.05 (0.04; 0.06) | 0.06 (0.03; 0.07) | 0.05 (0.04; 0.07) |
| LYM (×103) [cells/µL] | 2.14 (1.68; 2.46) # | 2.18 (1.88; 2.5) # | 1.92 (1.66; 2.17) | 1.87 (1.56; 2.10) |
| MON (×103) [cells/µL] | 0.59 (0.46; 0.76) # | 0.55 (0.49; 0.74) # | 0.62 (0.47; 0.77) | 0.46 (0.39; 0.52) |
Data presented as median and interquartile: Me (Q1; Q3). Statistically significant differences (p < 0.05) vs. controls are marked with #. Significance of differences between RVO and control group was estimated using the Mann–Whitney U non-parametric test. Significance of differences between BRVO vs. controls and CRVO vs. controls was estimated using the Kruskal–Wallis non-parametric test with Dunn’s multiple comparison test. RBC—Red Blood Cells, WBC—White Blood Cells, NEU—neutrophils, EOS—eosinophils, BAS—basophils, LYM—lymphocytes, MON—monocytes. BRVO—Branch Retinal Vein Occlusion, CRVO—Central Retinal Vein Occlusion, RVO—Retinal Vein Occlusion.